Home Types of Cancer Lung Cancer

Lung Cancer

Patritumab Deruxtecan Shows Tumor Response Across Multiple Resistance Mechanisms in Patients with Advanced EGFR-Mutated...

New data presented at this year’s annual meeting of the American Society of Clinical Oncology, held online June 4...

HERTHENA-Lung01 Study of Patritumab Deruxtecan Initiated in Patients with EGFR-Mutated NSCLC

A first patient has been dosed in HERTHENA-Lung01, a phase II study evaluating patritumab deruxtecan, a HER3 directed DXd...

X